medigraphic.com
ISSN 1561-3186 (Electronic)

2019, Number 2

<< Back

Rev Acta Médica 2019; 20 (2)

Hypertrophic lupus erythematosus

Castillo OAC, Burgois LL, Collazo CSE, Amador DME

Language: Spanish
References: 13
Page: 1-8
PDF size: 281.19 Kb.


ABSTRACT

Hypertrophic discoid lupus erythematosus is a rare form of chronic discoid lupus erythematosus, rare in the male gender. It manifests with hyperkeratotic lesions that compromise photoexposed areas. Generally, the natural history of the condition is marked by chronicity and resistance to therapy. The case of a patient with lesions of five years of evolution is presented, managed with a different diagnosis, years later due to exacerbation of the condition, he attends our institution, where he is clinically and histopathologically confirmed with hypertrophic chronic discoid lupus erythematosus. Treatment with thalidomide, and with later antimalarial medication, was initiated with a favorable response.


REFERENCES

  1. Bardek I, Basta Juzbašić A, Marinović B, Bukvić Z, Milavec Puretić V. Hypertrophic lupus erythematosus: case report. Acta Dermatovenerol Croat. 2009;17(2):134-8.

  2. Silva E, Labrador N, Sehtman A, Cabrera HN, Allevato MA. Lupus eritematoso discoide crónico hipertrófico. Buena respuesta terapéutica. Act Terap Dermatol. 2005;28:170-5.

  3. Sánchez JT. Enfoque terapéutico del lupus eritematoso cutáneo. Piel. 2002;17(8):386-90.

  4. Marsol IB, Rodríguez Caruncho C. Manifestaciones cutáneas del lupus eritematoso. Inmunología. 2010;29(3):100-10.

  5. Farley Loftus R, Elmariah SB, Ralston J, Kamino H, Franks AG. Hypertrophic discoid lupus erythematosus. Dermatol Online J. 2010;16(11):1.

  6. Salomón M, Frine Samalvides F, Gordillo J, Gutierrez C. Manifestaciones histopatoló-gicas del lupus eritematoso cutáneo en pacientes del Servicio de Dermatología del Hospital Nacional Cayetano Heredia, 2003- 2008. Folia Dermatol Peru. 2009;20(2):64-70.

  7. Wollina U, Hansel G. The use of topical calcineurin inhibitors in lupus erythematosus: an overview. J Eur Acad Dermatol Venereol. 2008;22(1):1-6.

  8. Gambini D, Carrera C, Passoni E, Muratori S, Berti E, Caputo R. Thalidomide treatment for hypertrophic cutaneus lupus erythematosus. J Dermatol Treat. 2004;15(6):365-71.

  9. Gupta U, Barman K, Saify K. Squamous cell carcinoma complicating an untreated chronic discoid lupus erythematosus (CDLE) lesion in a black female. J Dermatol. 2005;32(12):1010-3.

  10. Ferreira MV, Aguerópolis MC, Recarte M, Fritschy M. Lupus eritematoso discoide crónico hipertrófico. Arch Argent Dermatol. 2013;63:70-3.

  11. Gambini D, Carrera C, Passoni E, Muratori S, Berti E, Caputo R. Thalidomide treatment for hypertrophic cutaneus lupus erythematosus. J Dermatol Treat. 2004;15(6):365-71.

  12. 12 Gupta U, Barman K, Saify K. Squamous cell carcinoma complicating an untreated chronic discoid lupus erythematosus (CDLE) lesion in a black female. J Dermatol. 2005;32(12):1010-3.

  13. Ferreira MV, Aguerópolis MC, Recarte M, Fritschy M. Lupus eritematoso discoide crónico hipertrófico. Arch Argent Dermatol. 2013;63:70-3.




2020     |     www.medigraphic.com